image

The best stocks to buy since 1993

Our latest issue will be released in 14 days, don't miss out!

Supreme

February 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SUP
  • Price:
  • 114.5p
Supreme’s Q3 update confirmed trading is running ahead of expectations and triggered the fourth upgrade in six months. Supreme now expects sales for the year to end March to come in at £225m, with adjusted EBITDA of “at least £38.0m,” resulting in a 16% upgrade to  eps forecasts to 19.9p. The news came just a few hours after the Government’s Vaping Review said it is set to introduce a ban on disposable vaping, alongside new powers to restrict vape flavours and introduce plain packaging. Supreme has already implemented several pro-active measures. It estimates  disposable vaping will contribute £75.0m of sales  and £9.0m to operating profit and expects a material proportion, >50%, of disposable vaping demand to transition to alternativ ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe